All.Can Belgium is a national initiative from All.Can International, committed to an efficient approach to cancer care. As a non-profit organization, we bring together different stakeholders such as healthcare professionals, academic institutions, patient organizations, medical experts, health economists, industry
All.Can Belgium is a national initiative from All.Can International, committed to an efficient approach to cancer care. As a non-profit organization, we bring together different stakeholders such as healthcare professionals, academic institutions, patient organizations, medical experts, health economists, industry
Every year, almost 9,000 women [1] undergo a cone biopsy to treat precancerous lesions. Precancerous lesions are abnormal cells in the cervix that can develop into cervical cancer. They are detected through cervical screening. A cone biopsy is preceded by a colposcopy – a closer examination of the cervix. In…
Anal cancer is rare, almost always linked to HPV, and in many cases preventable — if we detect precancerous lesions in time. In an in-depth interview, Dr. Magali Surmont (UZ Brussels) shares how Belgium is taking action against anal cancer. She points to three key areas where we can truly…
Since January 2025, cervical cancer screening for women aged 30 and over has been carried out differently. The smear is now first tested for the presence of human papillomavirus (HPV), and only then, depending on the result of that first test, are the cells examined. There is a good reason…
The core of All.Can Belgium is collaboration, so new members, partners and organisations are always welcome. Are you also striving for efficient, innovative, sustainable and patient-centred cancer care? Join All.Can Belgium.
